JP2009530316A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530316A5
JP2009530316A5 JP2009500668A JP2009500668A JP2009530316A5 JP 2009530316 A5 JP2009530316 A5 JP 2009530316A5 JP 2009500668 A JP2009500668 A JP 2009500668A JP 2009500668 A JP2009500668 A JP 2009500668A JP 2009530316 A5 JP2009530316 A5 JP 2009530316A5
Authority
JP
Japan
Prior art keywords
agent
composition
contraceptive composition
contraceptive
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530316A (ja
JP5322918B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2007/000352 external-priority patent/WO2007106944A1/en
Publication of JP2009530316A publication Critical patent/JP2009530316A/ja
Publication of JP2009530316A5 publication Critical patent/JP2009530316A5/ja
Application granted granted Critical
Publication of JP5322918B2 publication Critical patent/JP5322918B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009500668A 2006-03-22 2007-03-21 避妊用組成物 Active JP5322918B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2006901474 2006-03-22
AU2006901474A AU2006901474A0 (en) 2006-03-22 Composition
PCT/AU2007/000352 WO2007106944A1 (en) 2006-03-22 2007-03-21 Contraceptive composition

Publications (3)

Publication Number Publication Date
JP2009530316A JP2009530316A (ja) 2009-08-27
JP2009530316A5 true JP2009530316A5 (enExample) 2010-04-08
JP5322918B2 JP5322918B2 (ja) 2013-10-23

Family

ID=38521950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500668A Active JP5322918B2 (ja) 2006-03-22 2007-03-21 避妊用組成物

Country Status (8)

Country Link
US (1) US8193248B2 (enExample)
EP (1) EP1996209B1 (enExample)
JP (1) JP5322918B2 (enExample)
CN (1) CN101405010B (enExample)
AU (1) AU2007229268B2 (enExample)
CA (1) CA2640978C (enExample)
ES (1) ES2558875T3 (enExample)
WO (1) WO2007106944A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100324146A1 (en) * 2008-02-22 2010-12-23 Starpharma Pty Ltd Dendrimeric Enzyme Inhibitors
WO2010033188A2 (en) * 2008-09-16 2010-03-25 Playtex Products, Llc. Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
US20110077263A1 (en) * 2009-09-29 2011-03-31 University Of Southern California Methods and Compositions of Toll-Like Receptor (TLR) Agonists
US20110086044A1 (en) * 2009-09-29 2011-04-14 University Of Southern California Compositions and Methods to Inhibit HPV Infection
CA2836168C (en) * 2011-05-16 2019-09-24 Starpharma Pty Ltd Method of treatment or prophylaxis of bacterial vaginosis
US20140315795A1 (en) 2012-10-26 2014-10-23 Nlife Therapeutics, S.L. Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types
WO2014113693A1 (en) * 2013-01-18 2014-07-24 University Of Utah Research Foundation Modified release osmotic pump for ph-responsive intravaginal drug delivery
WO2016007538A1 (en) * 2014-07-07 2016-01-14 Prophylaxis, Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
GB201617063D0 (en) * 2016-10-07 2016-11-23 Cambridge Design Research Llp Condoms

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
GB9407812D0 (en) 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
AUPO104496A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US6191120B1 (en) * 1998-03-25 2001-02-20 Wayne Hughes Institute Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions
US6192887B1 (en) * 1998-05-19 2001-02-27 The Pennsylvania State University Broad spectrum microbicidal and spermicidal compositions and methods having activity against sexually transmitted agents including papillomaviruses
AUPP584398A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
CA2402520A1 (en) * 2000-03-13 2001-09-20 Kenneth Beckman Biocidal methods and compositions
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
CA2346188A1 (en) * 2001-05-02 2002-11-02 Bradley Benson Male sexual aid device
AU2003225636A1 (en) 2002-03-05 2003-09-22 Ramot At Tel-Aviv University Ltd. Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
JP2005527546A (ja) * 2002-03-26 2005-09-15 イースタン ヴァージニア メディカル スクール 局所用殺菌剤および避妊薬としてのスラミンおよびその誘導体

Similar Documents

Publication Publication Date Title
JP2009530316A5 (enExample)
CA2632626C (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
JP2009531403A5 (enExample)
JP2004509061A5 (enExample)
CN101405010B (zh) 避孕组合物
JP2007197470A5 (enExample)
JP2017537158A5 (enExample)
EP3159351A3 (en) Modified 3'-azido-4'-ethynyl-nucleosides as antiviral agents
JP2007509902A5 (enExample)
JP2008505902A5 (enExample)
CA2441357A1 (en) Agent for the prevention and treatment of sexually transmitted diseases-i
JP2010536063A5 (enExample)
US10568855B2 (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides
JP2009527505A5 (enExample)
JP2004530737A5 (enExample)
JP2005514358A5 (enExample)
CA2441292A1 (en) Equine herpesvirus vaccine
JP3598168B2 (ja) 抗ウイルス剤
JPH11199647A5 (enExample)
JP2005520809A5 (enExample)
JP5213718B2 (ja) 殺微生物性デンドリマー組成物のデリバリーシステム
TW200524622A (en) Activated carbon for preventing pregnancy and sexually transmitted disease
RU2007143025A (ru) Полиморфизм додекагидроклопента[а]фенантренилового эфира тиофенкарбоновой кислоты
DeRossi et al. The management of oral human papillomavirus with topical cidofovir: a case report
US20090247639A1 (en) Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv